Exhibit 99.1 Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results • Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3% • Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the global medical device industry • Provides full-year 2024 financial guidance reflecting enhanced revenue growth and improved execution DURHAM, NC — March 12, 2024 — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) ...